108 related articles for article (PubMed ID: 8134576)
1. MR lymphography: study of a high-efficiency lymphotrophic agent.
Weissleder R; Heautot JF; Schaffer BK; Nossiff N; Papisov MI; Bogdanov A; Brady TJ
Radiology; 1994 Apr; 191(1):225-30. PubMed ID: 8134576
[TBL] [Abstract][Full Text] [Related]
2. Interstitial MR lymphography with iron oxide particles: results in tumor-free and VX2 tumor-bearing rabbits.
Taupitz M; Wagner S; Hamm B; Binder A; Pfefferer D
AJR Am J Roentgenol; 1993 Jul; 161(1):193-200. PubMed ID: 8517301
[TBL] [Abstract][Full Text] [Related]
3. MR lymphography with superparamagnetic iron nanoparticles in rats: pathologic basis for contrast enhancement.
Guimaraes R; Clément O; Bittoun J; Carnot F; Frija G
AJR Am J Roentgenol; 1994 Jan; 162(1):201-7. PubMed ID: 8273666
[TBL] [Abstract][Full Text] [Related]
4. Cervical lymph node metastases: MR imaging of gadofluorine M and monocrystalline iron oxide nanoparticle-47 in a rabbit model of head and neck cancer.
Choi SH; Han MH; Moon WK; Son KR; Won JK; Kim JH; Kwon BJ; Na DG; Weinmann HJ; Chang KH
Radiology; 2006 Dec; 241(3):753-62. PubMed ID: 17032913
[TBL] [Abstract][Full Text] [Related]
5. Ultrasmall superparamagnetic iron oxide: an intravenous contrast agent for assessing lymph nodes with MR imaging.
Weissleder R; Elizondo G; Wittenberg J; Lee AS; Josephson L; Brady TJ
Radiology; 1990 May; 175(2):494-8. PubMed ID: 2326475
[TBL] [Abstract][Full Text] [Related]
6. Positive contrast MR-lymphography using inversion recovery with ON-resonant water suppression (IRON).
Korosoglou G; Tang L; Kedziorek D; Cosby K; Gilson WD; Vonken EJ; Schär M; Sosnovik D; Kraitchman DL; Weiss RG; Weissleder R; Stuber M
J Magn Reson Imaging; 2008 May; 27(5):1175-80. PubMed ID: 18425827
[TBL] [Abstract][Full Text] [Related]
7. MR lymphography with a lymphotropic T1-type MR contrast agent: Gd-DTPA-PGM.
Harika L; Weissleder R; Poss K; Zimmer C; Papisov MI; Brady TJ
Magn Reson Med; 1995 Jan; 33(1):88-92. PubMed ID: 7891541
[TBL] [Abstract][Full Text] [Related]
8. MR lymphography with iron oxide particles: dose-response studies and pulse sequence optimization in rabbits.
Hamm B; Taupitz M; Hussmann P; Wagner S; Wolf KJ
AJR Am J Roentgenol; 1992 Jan; 158(1):183-90. PubMed ID: 1727343
[TBL] [Abstract][Full Text] [Related]
9. MR lymphography: evidence of extravasation of superparamagnetic nanoparticles into the lymph.
Clement O; Rety F; Cuenod CA; Siauve N; Carnot F; Bordat C; Siche M; Frija G
Acad Radiol; 1998 Apr; 5 Suppl 1():S170-2; discussion S183-4. PubMed ID: 9561073
[No Abstract] [Full Text] [Related]
10. MR lymphography using iron oxide nanoparticles in rats: pharmacokinetics in the lymphatic system after intravenous injection.
Réty F; Clément O; Siauve N; Cuénod CA; Carnot F; Sich M; Buisine A; Frija G
J Magn Reson Imaging; 2000 Nov; 12(5):734-9. PubMed ID: 11050643
[TBL] [Abstract][Full Text] [Related]
11. MR lymphography using iron oxide particles. Detection of lymph node metastases in the VX2 rabbit tumor model.
Taupitz M; Wagner S; Hamm B; Dienemann D; Lawaczeck R; Wolf KJ
Acta Radiol; 1993 Jan; 34(1):10-5. PubMed ID: 8427741
[TBL] [Abstract][Full Text] [Related]
12. Macromolecular intravenous contrast agent for MR lymphography: characterization and efficacy studies.
Harika L; Weissleder R; Poss K; Papisov MI
Radiology; 1996 Feb; 198(2):365-70. PubMed ID: 8596833
[TBL] [Abstract][Full Text] [Related]
13. Early MR lymphography with gadofluorine M in rabbits.
Misselwitz B; Platzek J; Weinmann HJ
Radiology; 2004 Jun; 231(3):682-8. PubMed ID: 15163808
[TBL] [Abstract][Full Text] [Related]
14. AMI-227-enhanced MR lymphography: usefulness for differentiating reactive from tumor-bearing lymph nodes.
Vassallo P; Matei C; Heston WD; McLachlan SJ; Koutcher JA; Castellino RA
Radiology; 1994 Nov; 193(2):501-6. PubMed ID: 7972768
[TBL] [Abstract][Full Text] [Related]
15. Experimental lymph node metastases: enhanced detection with MR lymphography.
Weissleder R; Elizondo G; Josephson L; Compton CC; Fretz CJ; Stark DD; Ferrucci JT
Radiology; 1989 Jun; 171(3):835-9. PubMed ID: 2717761
[TBL] [Abstract][Full Text] [Related]
16. Assessment of normal, inflammatory, and tumor-bearing lymph nodes with contrast-enhanced interstitial magnetic resonance lymphography: preliminary results in rabbits.
Herborn CU; Vogt FM; Lauenstein TC; Goyen M; Dirsch O; Corot C; Debatin JF; Ruehm SG
J Magn Reson Imaging; 2003 Sep; 18(3):328-35. PubMed ID: 12938128
[TBL] [Abstract][Full Text] [Related]
17. MR lymphangiography: imaging strategies to optimize the imaging of lymph nodes with ferumoxtran-10.
Harisinghani MG; Dixon WT; Saksena MA; Brachtel E; Blezek DJ; Dhawale PJ; Torabi M; Hahn PF
Radiographics; 2004; 24(3):867-78. PubMed ID: 15143236
[TBL] [Abstract][Full Text] [Related]
18. Magnetic resonance imaging diagnosis of metastatic lymph nodes in a rabbit model: efficacy of PJY10, a new ultrasmall superparamagnetic iron oxide agent, with monodisperse iron oxide core and multiple-interaction ligands.
Yoo RE; Choi SH; Cho HR; Jeon BS; Kwon E; Kim EG; Park J; Myeong WJ; Won JK; Lee YS; Kim JH; Park SW; Sohn CH
PLoS One; 2014; 9(9):e107583. PubMed ID: 25216040
[TBL] [Abstract][Full Text] [Related]
19. MR contrast agents in lymph node imaging.
Misselwitz B
Eur J Radiol; 2006 Jun; 58(3):375-82. PubMed ID: 16464554
[TBL] [Abstract][Full Text] [Related]
20. Comparison of two different iron oxide-based contrast agents for discrimination of benign and malignant lymph nodes.
Kinner S; Maderwald S; Albert J; Parohl N; Corot C; Robert P; Baba HA; Barkhausen J
Invest Radiol; 2012 Sep; 47(9):511-5. PubMed ID: 22864375
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]